Literatur
-
1
Leder K, Weller P F, Wilson M E.
Travel vaccines available in the United states.
Clin Inf Dis.
2001;
33
1553-1566
-
2
Joines R W, Blatter M, Abraham B, Xie F, De Clerq N, Baine Y, Reisinger K S, Kuhen A, Parenti D L.
A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults.
Vaccines.
2001;
19
4710-4719
-
3 Keystone J, Parsons J, Ford K. Reactogenicity and Immunogenicity of a combined vaccine against Hepatitis A and B in older Adults. IX Triennal International Symposium on Viral Hepatitis and Liver Disease, C324, 21 - 25.4.1996, Rome, Italy 1966
-
4
Junge U, Melching J, Dzuiba S.
Akute Hepatitis A trotz kombinierter Schutzimpfung gegen Hepatitis A und B.
Dtsch Med Wochenschr.
2002;
127
1581-1583
Autoren
Dr. med. Thomas Lander
Dr. Nils Matzen
GlaxoSmithKline GmbH & Co. KG
Leopoldstraße 175
80804 München
Telefon: 089/360440
Fax: 089/36044123